This Government Contract opportunity from Department Of Defense was posted on September 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Sole Source - EzPlaz

Closed

HT942726QE015Federal

Submission Closed09/16/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Pressure Sensitive Adhesive Plastic Strip SupplyThis subcontract, issued by Construction & Equipment MRO SVC I for the Department of Defense, involves the supply of clear, abrasion- and solvent-resistant polyurethane plastic strips for prime contractors on DLA supply contracts. The required materials must meet 3M P/N 8681HS specifications, featuring a removable paper backing liner score-slit at 1-inch intervals. The order consists of 23 rolls of 36-yard strips, each maintaining a shelf life of 24 months. The contract mandates strict compliance with NAVSEA J100-003D mercury-free and FED-STD-313 asbestos-free standards. This opportunity is designated as a Total Small Business Set-Aside under NAICS code 325412, with the place of performance located in San Diego, California. The response deadline for this procurement is October 26, 2026.

CONSTRUCTION & EQUIPMENT MRO SVC I

POSTED

DEADLINE

Solicitation # SPE2D2-26-R-0009

Solicitation SPE2D2-26-R-0009 is a federal procurement issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the acquisition of Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count boxes. The government is seeking offers from manufacturers or distributors to ensure an uninterrupted supply, with a total contract duration not to exceed five years. The procurement is conducted as a lowest price technically acceptable acquisition, where awards are based on technical acceptability regarding requirements and past performance, followed by the lowest evaluated aggregate price. The estimated quantity for the base year and subsequent option years is 473,905 boxes per period. Offerors must submit their proposals electronically via DIBBS by November 16, 2026. Required documentation includes a signed SF 1449, a price proposal, and either a Letter of Certification for manufacturers or a Letter of Commitment from the manufacturer for dealers and suppliers. Strict quality and regulatory standards apply, including mandatory FDA clearance and compliance with current Good Manufacturing Practices. Packaging must feature child-proof closures, non-glass bottles with a minimum 100cc volume, and GS1-128 or HIBC compliant bar coding at the unit-of-use level encoding the National Drug Code. All contractors must also adhere to the Drug Supply Chain Security Act and various FAR and DFARS clauses regarding trade agreements and cybersecurity.

MEDICAL SUPPLY CHAIN FSGB

POSTED

DEADLINE

Solicitation # SPE2D2-26-R-0012

Solicitation SPE2D2-26-R-0012 is a requirements contract issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the procurement of Febuxostat tablets in 30-count bottles. The requirement covers two strengths: 40mg and 80mg tablets. The acquisition is conducted as a Lowest Price Technically Acceptable (LPTA) procurement, where the award is granted to the responsible offeror who is determined to be technically acceptable and provides the lowest evaluated aggregate price. Technical acceptability is based on compliance with the Statement of Work and a review of past performance, including the status of FDA warning letters, violations, or failed inspections. The contract mandates strict adherence to FDA current Good Manufacturing Practice (cGMP) standards and requires products to have valid New Drug Applications (NDA) or Abbreviated New Drug Applications (ANDA), specifically preferring a Therapeutic Equivalence Code of A. Packaging must meet precise specifications, including a cylindrical bottle with a minimum 100cc volume, a 5.75-inch minimum circumference, and a child-proof safety cap. Labeling must be GS1-128 or HIBCC compliant and include linear bar coding at the unit-of-use level. Offers must be submitted exclusively through the Defense Logistics Agency Internet Bid Board System (DIBBS). Following several amendments, the final closing date for the receipt of offers is October 29, 2026, at 3:00 PM EST. Proposals must be organized into a non-price volume and a price proposal volume, including a Letter of Certification on manufacturer letterhead and specific FDA disclosures. The contract structure includes a base year and four option years, with an estimated base quantity of 76,388 bottles for the 40mg tablets.

Defense Logistics Agency

POSTED

DEADLINE

6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center

Solicitation # 36C24427Q0018

The Department of Veterans Affairs Network Contracting Office 4 is soliciting quotations for an indefinite-quantity contract to provide radiopharmaceuticals and calibration sources for the Nuclear Medicine Department at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The contract covers a base period from November 1, 2026, to October 31, 2031, with four additional option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, FDA, OSHA, and NHPP. Key deliverables include various cold kits and specific radiopharmaceuticals, with strict delivery requirements: routine orders must be received by 8:00 AM the following workday, and same-day orders must be delivered within two hours during normal business hours. The government will award the contract based on a comparative evaluation of price and past performance from the last three years, utilizing simplified acquisition procedures for commercial products. Technical requirements include specific labeling for radioactive materials and unit doses, as well as the provision of bar-labeled inserts for integration with the PineStar nuclear medicine information management system. If the contractor's system differs, they must provide data migration and training at no additional cost. Invoicing is to be submitted monthly and electronically via the Austin Payment Center. The solicitation is unrestricted, though price evaluation preference is provided for HUBZone small business concerns.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supplier of Electrical Insulation Tape (NSN 5970010139369)This subcontract involves the supply of 6,000 rolls of electrical insulation tape meeting NSN 5970010139369 critical application standards for prime contractors supporting the DLA Weapons Support ASC Commodities Division. The tape must have a non-extendable 18-month shelf life and be delivered FOB Destination to Portsmouth. All products must be marked and packaged in strict accordance with MIL-STD-129 and MIL-STD-2073-1E. The selected supplier must adhere to the Buy American Act and Berry Amendment requirements. Additionally, the contractor is required to maintain cybersecurity compliance as outlined in NIST SP 800-171. This opportunity falls under NAICS code 325412 and is managed by the Department of Defense.

DLA WEAPONS SUPPORT ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supplier of White Electrical Insulation Tape (NSN 5970002848565)This subcontract involves the supply of white electrical insulation tape to support prime contractors for the DLA Weapons Support Nuclear Reactor Program. The required tape must adhere to NSN 5970002848565 and CID A-A-59770A specifications, featuring a nominal length of 2160 inches, a width of 0.750 inches, and a thickness of 0.0070 inches. All products must be marked according to MIL-STD-129 and packaged in compliance with MIL-STD-2073-1E and RP001. The finished rolls are to be delivered FOB Origin to Dobbins AFB and the USNS Washington Chambers. This procurement falls under NAICS code 325412 and is managed by the Department of Defense. Interested parties should note the response deadline of October 26, 2026.

DLA WEAPONS SUPPORT NUCLEAR REACTOR PROGRAM

POSTED

DEADLINE

Docusate Sodium Capsules SupplierThis subcontract opportunity is for the supply of pharmaceutical-grade Docusate Sodium 10 mg capsules to support prime contractors under the Department of Defense Medical Supply Chain Pharm FSA. The supplier must manufacture capsules that strictly adhere to USP standards and FDA regulations, ensuring a 36-month shelf life and maintaining controlled room temperature storage between 20 and 25 degrees Celsius. The contract requires the provider to hold RX Only licensing and comply with the DLA Master List of Technical and Quality Requirements. Deliverables consist of five packages containing 100 unit dose capsules each. Interested parties should note the response deadline of October 19, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Poison Ivy Treatment Skin Wash SupplierThis subcontract involves the supply of a topical skin wash solution for the treatment of poison ivy, oak, and sumac to support prime contractors on Department of Defense Medical Supply Chain Pharm FSA projects. The required product must be provided in 1-ounce tubes that adhere to NSN 6505016112071 specifications and maintain a shelf life of 120 months. The supplier must be FDA registered and ensure full compliance with Medical Marking Standard No. 1 and MIL-STD-129. The contract stipulates the delivery of one unit of the skin wash FOB Destination to South Charleston, West Virginia. This opportunity falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Dextrose in Lactated Ringer's InjectionThis subcontract involves the supply of sterile, nonpyrogenic, and latex-free Dextrose in Lactated Ringer's Injection for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The scope of work requires the manufacture or sourcing of 1,000 ml containers with a specific chemical composition including Dextrose Hydrous, Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride. The contract specifically calls for the delivery of five packages of NSN 6505001161064 to be performed at Fort Bragg. Strict adherence to FDA regulations is mandatory, and the provider must comply with the Buy American Act and Berry Amendment. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Interested parties must note the response deadline of October 19, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ethyl Alcohol-Based Hand Sanitizer (NSN 8520-01-346-9200)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sodium Chloride 0.9% Injection ManufacturerThis subcontract involves the manufacture and supply of finished medical products for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider will produce sterile Sodium Chloride 0.9% Injection, specifically filling and sealing 500 ML containers in packages of 24. All products must adhere to USP standards and maintain a minimum shelf life of 24 months. To qualify, the manufacturer must operate a sterile pharmaceutical facility and maintain active FDA registration. The contract falls under NAICS code 325412 and focuses on the delivery of finished, packaged medical supplies to meet specific government requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Albuterol Inhalation Aerosol SupplierThis subcontract involves the supply of prescription-only Albuterol Inhalation Aerosol to prime contractors supporting Department of Defense medical supply chain projects. The required product consists of pressurized aluminum canisters providing 90 mcg of albuterol base per actuation for a total of 60 actuations, equipped with a counter, plastic actuator, and strapcap. All supplies must be FDA approved and adhere to Medical Marking Standard No. 1. The contract specifies the delivery of 10 units, each maintaining a minimum remaining shelf life of 15 months. Performance for this requirement is located at Fort Campbell, Kentucky, under the oversight of the Medical Supply Chain Pharm FSA. The solicitation was posted on October 13, 2026, with a response deadline of October 19, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The Defense Health Agency intends to award a firm-fixed price Indefinite Delivery/Indefinite Quantity contract to Vascular Solutions LLC on a sole source basis. This action is driven by a critical requirement for FDA approved Freeze Dried Plasma for transfusions when other plasma products are unavailable. Vascular Solutions LLC is identified as the only source capable of meeting these requirements, as their product, EZPLAZ, is the first and only licensed FDP product currently on the market. While the agency intends to proceed with a sole source award, it is issuing this notice to determine if other competitive sources exist. Interested parties must submit a capability statement including technical, management, and cost data by September 16, 2026, to demonstrate their ability to provide an FDA approved FDP product. These submissions must be sent via email to the designated points of contact and must not exceed five pages. If no qualifying responses are received, the contract will be awarded to Vascular Solutions LLC without further notice.

General Info

DHA seeks alternative FDA approved Freeze Dried Plasma providers to avoid sole source contracting.

Agency

Department Of Defense → Defense Health Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

MD, 21702, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhaseClosed

PostedAug 25

Sources Sought

Notice updatedSep 1

Notice type changed from Sources Sought to Special Notice. Response deadline changed from Sep 1, 2026 to Sep 16, 2026. The notice title changed. The notice description changed.

Response DeadlineSep 16

Deadline has passed

Submission Closed

09/16/2026, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency

Contacts2 people available

OfficeFORT DETRICK, MD, 21702, USA

Organization / AgencyDepartment Of Defense → Defense Health Agency

Office AddressFORT DETRICK, MD, 21702, USA

Contacts

Timothy Kelly

contact@example.gov

Shannon Lertora

contact@example.gov

Full Description

The Defense Health Agency (DHA) Contracting Activity (DHACA), on behalf of the DHA’s Portfolio Acquisition Executive Medical Products (PAE MP), intends to issue a firm-fixed price Indefinite Delivery/Indefinite Quantity contract on a sole source basis under the authority of the Revolutionary Federal Acquisition Regulation (FAR) Overhaul, FAR 6.103-1, only one responsible source and no other supplies or services will satisfy agency requirements, to Vascular Solutions LLC, 6420 Sycamore Ct N, Maple Grove, Minnesota 55369-6032.

Vascular Solutions, LLC is the only source able to meet the Government’s requirements. The Government has a has a critical requirement for supply of a Food and Drug Administration (FDA) approved Freeze Dried Plasma (FDP) product for transfusion when plasma is required and other plasma products are not available. The FDA approved Vascular Solutions, LLC FDP product, EZPLAZ™, on 29 July 2026. Vascular Solutions LLC holds the first and only FDA-approved (licensed) FPD product on the market.

This Notice of Intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Responses must be supported with clear and convincing evidence articulating the ability to provide FDA approved FDP product. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. If no written responses are received by the date listed below, an Indefinite Delivery/Indefinite Quantity contract will be awarded without further remark.

Capability statements are due by 3:00 PM local time, 16 September 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: timothy.j.kelly169.civ@health.mil and shannon.p.lertora.civ@health.mil.